PECULIARITIES OF COVID-19 PNEUMONIA IN CHILDREN WITH BRONCHIAL ASTHMA IN THE KYRGYZ REPUBLIC
DOI:
https://doi.org/10.54890/.v4i4.1068Abstract
Purpose of the study: to conduct a retrospective analysis of the characteristics of the clinical picture of pneumonia with positive and negative tests for COVID-19 in children withbronchial asthma in children in the Kyrgyz Republic. Materials and methods. The case-control study compared two groups aged 7 to 17 years who were ill from September 2020 to February 2021. The clinical and laboratory characteristics of Covid-19 pneumonia in children with bronchial asthma were studied. Results: The pattern of Covid-19 pneumonia differed from usual pneumonia in children with asthma (p<0.001). A correlation was identified between data in the anamnesis of children with bronchial asthma and Covid-19 diseases in children with existing bronchial asthma (p<0.001). Conclusions: Susceptibility to Covid-19 was observed in children with existing asthma. Children with uncontrolled asthma had an increased risk of hospitalization and more severe asthma.
Keywords:
children, bronchial asthma, pneumonia, Covid-19.References
1. Chatziparasidis G, Kantar A. COVID-19 in Children with Asthma. Lung. 2021 Feb;199(1):7-12. https://doi.org/10.1007/s00408-021-00419-9
2. Boechat JL, Wandalsen GF, Kuschnir FC, Delgado L. COVID-19 and Pediatric Asthma: Clinical and Management Challenges. Int J Environ Res Public Health. 2021 Jan 26;18(3):1093. https://doi.org/10.3390/ijerph18031093
3. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020 Jun;109(6):1088-1095. https://doi.org/10.1111/apa.15270
4. CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426. https://doi.org/10.15585/mmwr.mm6914e4
5. Баранов А.А., Намазова-Баранова Л.С., Хаитов Р.М. Согласованные рекомендации по ведению детей с аллергическими болезнями в период пандемии нового коронавируса SARS-CoV-2 (инфекции COVID-19). Педиатрическая фармакология. 2020;17(3):119–122. [Baranov A.A., Namazova-Baranova L.S., Xaitov P.M. Soglasovannye rekomendacii po vedeniy detei s allergicheskimi boleznyami v period pandemii novogo koranovirusa SARS-CoV-2 (infekciya COVID-19).Pediatricheskaya pharmakologia. 2020;17(3):119–122. (In Russ.)]. https://doi.org/10.15690/pf.v17i2.2097
6. Сулайманов Ш.А., Муратова Ж.К. Аллергические заболевания у детей в условиях пандемии новой корановирусной инфекции. Вестник КГМА им. И.К. Ахунбаева. 2021;3:92-105. [Sulaimanov Sh.A., Muratova Zh.K. Allergic diseases in children under conditions of new Coronavirus infection pandemic. Vestnik KGMA n.a. I.K. Akhunbayev. 2021;3:92-105. (In Russ.)].
7. Maltezou HC, Magaziotou I, Dedoukou X, Eleftheriou E, Raftopoulos V, Michos A et all. Children and Adolescents with SARS-CoV-2 infection: epidemiology, clinical course and viral loads. Pediatr Infect Dis J. 2020 Dec; 39(12):e388-e392. https://doi.org/10.1097/INF.0000000000002899
8. Rajapakse N, Dixit D. Human and novel coronavirus infections in children: a review. Paediatr Int Child Health. 2021 Feb;41(1):36-55. https://doi.org/10.1080/ 20469047.2020.1781356
9. Sansone NMS, Valencise FE, Bredariol RF, Peixoto AO, Lima Marson FA. Profile of coronavirus disease enlightened asthma as a protective factor against death: An epidemiology study from Brazil during the pandemic. Front Med (Lausanne). 2022 Nov 29;9:953084. https://doi.org/10.3389/fmed.2022.953084
10. Riggioni C, Comberiati P, Giovannini M, Agache I, Akdis M, Alves-Correia M et all. A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy. 2020 Oct;75(10):2503-2541. https://doi.org/10.1111/all.14449
11. Gao YD, Agache I, Akdis M, Agache I, Akdis M, Alves-Correia M et all. The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19. Int Immunol. 2022 Mar 25;34(4):177-188. https://doi.org/10.1093/intimm/dxab107
12. Rao S, Hurst JH, Zhao C, Goldstein BA, Thomas L, Lang JE et all. Asthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents. Pediatrics. 2022 Jun 1;149(6):e2021056164. https://doi.org/10.1542/peds.2021-056164
13. Ramakrishnan RK, Al Heialy S, Hamid Q. Implications of preexisting asthma on COVID-19 pathogenesis. Am J Physiol Lung Cell Mol Physiol. 2021 May 1;320(5):L880-L891. https://doi.org/10.1152/ajplung.00547.2020
14. Munblit D, Greenhawt M, Brough HA, Pushkareva A, Karimova D, Demidova A et al. Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics. Pediatr Allergy Immunol. 2022 Oct; 33(10):e13851. https://doi.org/10.1111/pai.13851
15. Boechat JL, Wandalsen GF, Kuschnir FC, Delgado L. COVID-19 and Pediatric Asthma: Clinical and Management Challenges. Int J Environ Res Public Health. 2021 Jan 26;18(3):1093. https://doi.org/10.3390/ijerph18031093
16. Ghosh S, Das S, Mondal R, Abdullah S, Sultana Sh, Singh S et all. A review on the effect of COVID-19 in type 2 asthma and its management. Int Immunopharmacol. 2021 Feb; 91:107309. https://doi.org/10.1016/j.intimp.2020.107309
17. Papadopoulos NG, Custovic A, Deschildre A, Mathioudakis AG, Phipatanakul W, Wong G et all. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2592-2599.e3. https://doi.org/10.1016/j.jaip.2020.06.001
18. Sokolowska M, Lukasik ZM, Agache I, Akdis CA, Akdis D, Akdis M et all. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020 Oct;75(10):2445-2476. https://doi.org/10.1111/all.14462
Downloads
Published
How to Cite
Issue
Section
